Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate.
Paolo MartellettiEnrico BentivegnaMichelangelo LucianiValerio SpuntarelliPublished in: SN comprehensive clinical medicine (2020)
Headache occurs in only about 13% of patients within the cohort of presenting COVID-19 symptoms. The hypothesis that such a painful symptomatic picture could be considered a prognostic factor for COVID-19 positive evolution or its trend of severity, or the co-generation of hyposmia/anosmia and/or hypogeusia/ageusia, needs robust epidemiological data, punctual pathophysiological demonstrations, and a detailed comparative analysis on drug-drug interactions (DDIs).